AMP as a low-energy charge signal autonomously initiates assembly of axin-ampk-lkb1 complex for AMPK activation

Cell Metabolism

Volumn 18, Issue 4, 2013, Pages 546-555

  Zhang, Ya Lin ^a   Guo, Huiling ^a   Zhang, Chen Song ^a   Lin, Shu Yong ^a   Yin, Zhenyu ^a   Peng, Yongying ^a   Luo, Hui ^a   Shi, Yuzhe ^a   Lian, Guili ^a   Zhang, Cixiong ^a   Li, Mengqi ^a   Ye, Zhiyun ^a   Ye, Jing ^b   Han, Jiahuai ^a   Li, Peng ^c   Wu, Jia Wei ^c   Lin, Sheng Cai ^a  

^a XIAMEN UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENYLATE KINASE; AXIN; GLUCOSE; PROTEIN KINASE LKB1;

ARTICLE; AXIN GENE; CELL ENERGY; CELL FREE SYSTEM; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FATTY LIVER; GENE; HOMEOSTASIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; SIGNAL TRANSDUCTION; STARVATION;

ADENOVIRIDAE;

ACETYL-COA CARBOXYLASE; ADENOSINE MONOPHOSPHATE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AXIN PROTEIN; CELL LINE; CELL-FREE SYSTEM; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; LIPID METABOLISM; LIVER; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84885142437     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.09.005     Document Type: Article

References (57)

1. Adams, J., Chen, Z.P., Van Denderen, B.J., Morton, C.J., Parker, M.W., Witters, L.A., Stapleton, D., and Kemp, B.E. (2004). Intrasteric control of AMPK via the gamma1 subunit AMP allosteric regulatory site. Protein Sci. 13, 155-165.
2. Assifi, M.M., Suchankova, G., Constant, S., Prentki, M., Saha, A.K., and Ruderman, N.B. (2005). AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. Am. J. Physiol. Endocrinol. Metab. 289, E794-E800.
3. Baas, A.F., Boudeau, J., Sapkota, G.P., Smit, L., Medema, R., Morrice, N.A., Alessi, D.R., and Clevers, H.C. (2003). Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J. 22, 3062-3072.
4. Bateman, A. (1997). The structure of a domain common to archaebacteria and the homocystinuria disease protein. Trends Biochem. Sci. 22, 12-13.
5. Boudeau, J., Baas, A.F., Deak, M., Morrice, N.A., Kieloch, A., Schutkowski, M., Prescott, A.R., Clevers, H.C., and Alessi, D.R. (2003). MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J. 22, 5102-5114.
6. Carling, D., Thornton, C., Woods, A., and Sanders, M.J. (2012). AMP-activated protein kinase: new regulation, new roles? Biochem. J. 445, 11-27.
7. Chen, L., Jiao, Z.H., Zheng, L.S., Zhang, Y.Y., Xie, S.T., Wang, Z.X., and Wu, J.W. (2009). Structural insight into the autoinhibition mechanism of AMP-activated protein kinase. Nature 459, 1146-1149.
8. Chen, L., Wang, J., Zhang, Y.Y., Yan, S.F., Neumann, D., Schlattner, U., Wang, Z.X., and Wu, J.W. (2012). AMP-activated protein kinase undergoes nucleotide-dependent conformational changes. Nat. Struct. Mol. Biol. 19, 716-718.
9. Crute, B.E., Seefeld, K., Gamble, J., Kemp, B.E., and Witters, L.A. (1998). Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase. J. Biol. Chem. 273, 35347-35354.
10. Davies, S.P., Sim, A.T., and Hardie, D.G. (1990). Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase. Eur. J. Biochem. 187, 183-190.
11. Davies, S.P., Helps, N.R., Cohen, P.T., and Hardie, D.G. (1995). 50-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett. 377, 421-425.
12. Guo, H.L., Zhang, C., Liu, Q., Li, Q., Lian, G., Wu, D., Li, X., Zhang, W., Shen, Y., Ye, Z., et al. (2012). The Axin/TNKS complex interacts with KIF3A and is required for insulin-stimulated GLUT4 translocation. Cell Res. 22, 1246-1257.
13. Hardie, D.G., and Alessi, D.R. (2013). LKB1 and AMPK and the cancer-metabolism link-ten years after. BMC Biol. 11, 36.
14. Hardie, D.G., Ross, F.A., and Hawley, S.A. (2012a). AMP-activated protein kinase: a target for drugs both ancient and modern. Chem. Biol. 19, 1222-1236.
15. Hardie, D.G., Ross, F.A., and Hawley, S.A. (2012b). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262.
16. Hawley, S.A., Selbert, M.A., Goldstein, E.G., Edelman, A.M., Carling, D., and Hardie, D.G. (1995). 50-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J. Biol. Chem. 270, 27186-27191.
17. Hawley, S.A., Davison, M., Woods, A., Davies, S.P., Beri, R.K., Carling, D., and Hardie, D.G. (1996). Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271, 27879-27887.
18. Hawley, S.A., Boudeau, J., Reid, J.L., Mustard, K.J., Udd, L., Mäkelä, T.P., Alessi, D.R., and Hardie, D.G. (2003). Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2, 28.
19. Hawley, S.A., Pan, D.A., Mustard, K.J., Ross, L., Bain, J., Edelman, A.M., Frenguelli, B.G., and Hardie, D.G. (2005). Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9-19.
20. Hong, S.P., Leiper, F.C., Woods, A., Carling, D., and Carlson, M. (2003). Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc. Natl. Acad. Sci. USA 100, 8839-8843.
21. Hudson, E.R., Pan, D.A., James, J., Lucocq, J.M., Hawley, S.A., Green, K.A., Baba, O., Terashima, T., and Hardie, D.G. (2003). A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr. Biol. 13, 861-866.
22. Hurley, R.L., Anderson, K.A., Franzone, J.M., Kemp, B.E., Means, A.R., and Witters, L.A. (2005). The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280, 29060-29066.
23. Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006). TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126, 955-968.
24. Iseli, T.J., Walter, M., van Denderen, B.J., Katsis, F., Witters, L.A., Kemp, B.E., Michell, B.J., and Stapleton, D. (2005). AMP-activated protein kinase beta subunit tethers alpha and gamma subunits via its C-terminal sequence (186-270). J. Biol. Chem. 280, 13395-13400.
25. Kemp, B.E. (2004). Bateman domains and adenosine derivatives form a binding contract. J. Clin. Invest. 113, 182-184.
26. Kneeman, J.M., Misdraji, J., and Corey, K.E. (2012). Secondary causes of nonalcoholic fatty liver disease. Therap. Adv. Gastroenterol. 5, 199-207.
27. Levine, A.J., and Puzio-Kuter, A.M. (2010). The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330, 1340-1344.
28. Li, Q., Lin, S., Wang, X., Lian, G., Lu, Z., Guo, H., Ruan, K., Wang, Y., Ye, Z., Han, J., and Lin, S.C. (2009). Axin determines cell fate by controlling the p53 activation threshold after DNA damage. Nat. Cell Biol. 11, 1128-1134.
29. Li, Y., Xu, S., Mihaylova, M.M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J.Y., et al. (2011). AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376-388.
30. Lin, Y.Y., Kiihl, S., Suhail, Y., Liu, S.Y., Chou, Y.H., Kuang, Z., Lu, J.Y., Khor, C.N., Lin, C.L., Bader, J.S., et al. (2012). Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK. Nature 482, 251-255.
31. Liu, W., Rui, H., Wang, J., Lin, S., He, Y., Chen, M., Li, Q., Ye, Z., Zhang, S., Chan, S.C., et al. (2006). Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia. EMBO J. 25, 1646-1658.
32. Moore, F., Weekes, J., and Hardie, D.G. (1991). Evidence that AMP triggers phosphorylation as well as direct allosteric activation of rat liver AMP-activated protein kinase. A sensitive mechanism to protect the cell against ATP depletion. Eur. J. Biochem. 199, 691-697.
33. Motoshima, H., Goldstein, B.J., Igata, M., and Araki, E. (2006). AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer. J. Physiol. 574, 63-71.
34. Neumann, D., Woods, A., Carling, D., Wallimann, T., and Schlattner, U. (2003). Mammalian AMP-activated protein kinase: functional, heterotrimeric complexes by co-expression of subunits in Escherichia coli. Protein Expr. Purif. 30, 230-237.
35. Oakhill, J.S., Chen, Z.P., Scott, J.W., Steel, R., Castelli, L.A., Ling, N., Macaulay, S.L., and Kemp, B.E. (2010). b-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK). Proc. Natl. Acad. Sci. USA 107, 19237-19241.
36. Oakhill, J.S., Steel, R., Chen, Z.P., Scott, J.W., Ling, N., Tam, S., and Kemp, B.E. (2011). AMPK is a direct adenylate charge-regulated protein kinase. Science 332, 1433-1435.
37. Pang, T., Xiong, B., Li, J.Y., Qiu, B.Y., Jin, G.Z., Shen, J.K., and Li, J. (2007). Conserved alpha-helix acts as autoinhibitory sequence in AMP-activated protein kinase alpha subunits. J. Biol. Chem. 282, 495-506.
38. Rui, Y., Xu, Z., Lin, S., Li, Q., Rui, H., Luo, W., Zhou, H.M., Cheung, P.Y.,Wu, Z., Ye, Z., et al. (2004). Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation. EMBO J. 23, 4583-4594.
39. Sanders, M.J., Grondin, P.O., Hegarty, B.D., Snowden, M.A., and Carling, D. (2007). Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 403, 139-148.
40. Scott, J.W., Hawley, S.A., Green, K.A., Anis, M., Stewart, G., Scullion, G.A., Norman, D.G., and Hardie, D.G. (2004). CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Invest. 113, 274-284.
41. Shaw, R.J., Kosmatka, M., Bardeesy, N., Hurley, R.L., Witters, L.A., DePinho, R.A., and Cantley, L.C. (2004). The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA 101, 3329-3335.
42. Shaw, R.J., Lamia, K.A., Vasquez, D., Koo, S.H., Bardeesy, N., Depinho, R.A., Montminy, M., and Cantley, L.C. (2005). The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-1646.
43. Stamos, J.L., and Weis, W.I. (2013). The b-catenin destruction complex. Cold Spring Harb. Perspect. Biol. 5, a007898.
44. Steinberg, G.R., and Kemp, B.E. (2009). AMPK in Health and Disease. Physiol. Rev. 89, 1025-1078.
45. Strovel, E.T., Wu, D., and Sussman, D.J. (2000). Protein phosphatase 2Calpha dephosphorylates axin and activates LEF-1-dependent transcription. J. Biol. Chem. 275, 2399-2403.
46. Suter, M., Riek, U., Tuerk, R., Schlattner, U., Wallimann, T., and Neumann, D. (2006). Dissecting the role of 50-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J. Biol. Chem. 281, 32207-32216.
47. Suzuki, T., Bridges, D., Nakada, D., Skiniotis, G., Morrison, S.J., Lin, J.D., Saltiel, A.R., and Inoki, K. (2013). Inhibition of AMPK catabolic action by GSK3. Mol. Cell 50, 407-419.
48. van Ginneken, V., Verhey, E., Poelmann, R., Ramakers, R., van Dijk, K.W., Ham, L., Voshol, P., Havekes, L., Van Eck, M., and van der Greef, J. (2007). Metabolomics (liver and blood profiling) in a mouse model in response to fasting: a study of hepatic steatosis. Biochim. Biophys. Acta 1771, 1263-1270.
49. Vousden, K.H. (2010). Alternative fuel-another role for p53 in the regulation of metabolism. Proc. Natl. Acad. Sci. USA 107, 7117-7118.
50. Wang, M.Y., and Unger, R.H. (2005). Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone. Am. J. Physiol. Endocrinol. Metab. 288, E216-E221.
51. Woods, A., Johnstone, S.R., Dickerson, K., Leiper, F.C., Fryer, L.G., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., and Carling, D. (2003). LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13, 2004-2008.
52. Woods, A., Dickerson, K., Heath, R., Hong, S.P., Momcilovic, M., Johnstone, S.R., Carlson, M., and Carling, D. (2005). Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2, 21-33.
53. Wu, Y., Song, P., Xu, J., Zhang, M., and Zou, M.H. (2007). Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J. Biol. Chem. 282, 9777-9788.
54. Xiao, B., Heath, R., Saiu, P., Leiper, F.C., Leone, P., Jing, C., Walker, P.A., Haire, L., Eccleston, J.F., Davis, C.T., et al. (2007). Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 449, 496-500.
55. Zeng, L., Fagotto, F., Zhang, T., Hsu, W., Vasicek, T.J., Perry, W.L., 3rd, Lee, J.J., Tilghman, S.M., Gumbiner, B.M., and Costantini, F. (1997). The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90, 181-192.
56. Zeqiraj, E., Filippi, B.M., Deak, M., Alessi, D.R., and van Aalten, D.M. (2009). Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation. Science 326, 1707-1711.
57. Zhu, L., Chen, L., Zhou, X.M., Zhang, Y.Y., Zhang, Y.J., Zhao, J., Ji, S.R., Wu, J.W., and Wu, Y. (2011). Structural insights into the architecture and allostery of full-length AMP-activated protein kinase. Structure 19, 515-522.